Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Published on by Academic Excellence

Prof. Dr. Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Prof. Dr. Inamul Hasan Madar | Medicine | Yenepoya Universtiy |India

Dr. Inamul Hasan Madar is a distinguished researcher and educator in the field of biochemistry with a specialization in oncology proteogenomics. He earned his PhD from Korea University, a globally ranked institution, and has since developed extensive expertise in cancer genomics, multiomics integration, and bioinformatics. With a strong commitment to advancing medical research, Dr. Madar has served as an adjunct faculty at Saveetha Medical College (SIMATS), where he has mentored PhD, MD, MBBS, and MSc students in cutting-edge biomedical sciences. His international research experience includes appointments at Korea University and Hanyang University in South Korea, where he contributed to high-impact oncology projects. As Director and Lead of Canary Oncoceutics India, he has bridged the gap between research and industry by leading innovative onco-therapeutic initiatives. Widely published in top-tier journals, Dr. Madar has also served as a reviewer for international journals and as a member of prestigious scientific societies worldwide.

Author profile

Orcid

Education

Dr. Madar’s academic journey reflects a deep pursuit of excellence in biomedical sciences. He earned his PhD in Biochemistry, specializing in Onco-Proteogenomics, from Korea University, Seoul, ranked among the top global universities. His doctoral work focused on proteogenomic profiling and cancer biomarker discovery, positioning him at the forefront of precision oncology. Before this, he pursued advanced training in bioinformatics, molecular biology, and proteomics, equipping him with multidisciplinary skills to tackle complex biomedical challenges. His postgraduate education emphasized molecular diagnostics and computational approaches, while his undergraduate studies laid the foundation in biochemistry and clinical applications. Dr. Madar has also completed specialized training programs in next-generation sequencing (NGS), computational modeling, molecular docking, and drug discovery pipelines. Furthermore, he has been actively engaged in faculty development programs, including pedagogy training for undergraduate teaching in life sciences and biotechnology. This comprehensive educational background underscores his ability to combine research innovation with academic excellence.

Experience

Dr. Madar’s professional experience spans academia, research, and industry. He currently serves as Adjunct Faculty at Saveetha Medical College, SIMATS, where he mentors MBBS, MD, MSc, MPhil, and PhD students in research methodologies, cancer biology, and bioinformatics. He is also Director and Lead (Marketing) at Canary Oncoceutics India, overseeing translational oncology research and innovation in oncoceutical product development. Internationally, he worked as a Visiting Scientist at Korea University, specializing in proteogenomics, and as a Researcher at Hanyang University, Seoul, in bioengineering. In India, his previous roles include Scientist & Course Coordinator at Biocuration, where he designed genomics and drug development modules, and Junior Scientist at iPro Technologies. He has also contributed as a guest lecturer at Bharathidasan University, training future biochemists. His expertise extends to designing computational pipelines, analyzing multiomics datasets, and leading cross-disciplinary projects that bridge laboratory science and clinical application, particularly in cancer therapeutics and biomarker discovery.

Awards and Honors

Dr. Inamul Hasan Madar has received widespread recognition for his contributions to biomedical research and education. His publications in high-impact journals such as Nature Cancer, Oncotarget, Briefings in Bioinformatics, and Molecular Cancer have positioned him among leading voices in proteogenomics and cancer research. He has served as a peer reviewer for several prestigious journals, including Nature’s Scientific Reports, Frontiers in Oncology, BMC Medical Genomics, and Journal of Translational Medicine. He has been actively involved in international professional societies, including the American Association of Cancer Research (AACR), American Society for Biochemistry and Molecular Biology (ASBMB), International Society of Computational Biology (ISCB), and South African and Korean Mass Spectrometry Societies. His leadership roles include serving as Vice President of ISCB-RSG India, demonstrating his dedication to strengthening scientific networks. He has also mentored numerous graduate and medical students, guiding them to publish impactful research, file patents, and develop translational medical applications.

Research Focus

Dr. Madar’s research focus lies at the intersection of cancer genomics, proteogenomics, and computational biology. He specializes in integrating multiomics datasets to identify novel biomarkers and therapeutic targets for treatment-resistant cancers, particularly cervical, prostate, and oral squamous cell carcinoma. His expertise in next-generation sequencing (RNA-Seq, Exome-Seq) and bioinformatics has enabled him to develop innovative pipelines for cancer biomarker discovery, molecular subtyping, and clinical variant interpretation. Beyond oncology, he has contributed to research in neurobiology, metabolic disorders, cardiovascular protection, and bioactive peptides against diabetes and obesity. His translational approach emphasizes the “bench-to-bedside” concept, applying computational models and molecular profiling to guide precision medicine strategies. Dr. Madar has also explored theranostic targets, signaling networks, and novel oncoceutical formulations. His interdisciplinary collaborations with international research groups have advanced drug design, CAR-T therapy applications, and personalized treatment strategies, positioning him as a pioneer in cancer research and translational medicine.

Publications

  • Correction to: Proteogenomic characterization of molecular and cellular targets for treatment-resistant cervical cancers.

  • Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma.

  • Proteogenomic characterization of treatment-resistant subtypes in cervical cancers.

  • Theranostic Target NSUN2 uncovered with systematic assembly of 805 datasets.

  • Unravelling the phosphoregulatory network of PKC-delta (PKC-δ).

  • BDNF-TrkB signalling: A neurotrophic pathway to cardiovascular protection.

  • Physiological activities of bioactive peptides against diabetes and obesity.

  • SGLT2 inhibitors as dual therapeutic targets for cardiovascular and renal health.

  • Biobased nanomaterials and rhizobacteria for sustainable plant growth.

  • CAR-T therapy in oral squamous cell carcinoma: Current innovations and future prospects.

Conclusion

Dr. Inamul Hasan Madar exemplifies excellence in translational medicine, combining cutting-edge cancer research with dedicated academic mentorship. His impactful publications, international collaborations, and leadership in oncology research position him as a transformative figure in biomedical sciences. Through his expertise in proteogenomics and bioinformatics, he continues to advance precision medicine while inspiring the next generation of medical researchers.

Yong Chul Lee | Medicine | Best Researcher Award

Published on by Academic Excellence

Prof. Dr. Yong Chul Lee | Medicine | Best Researcher Award

👤  Prof. Dr. Yong Chul Lee, Department of Internal Medicine, JEONBUK National University, Medical School, South Korea

Dr. YongChul Lee, MD, PhD, is a distinguished professor and researcher in respiratory medicine and allergy at JEONBUK National University Medical School, South Korea. With over 30 years of clinical and academic expertise, Dr. Lee is renowned for his contributions to respiratory diseases, asthma, and immunology. His career spans groundbreaking research, editorial roles in prestigious journals, and leadership in national and international organizations. As a principal investigator, he has directed pivotal projects in airway remodeling, severe asthma, and pulmonary disorders. Dr. Lee’s accolades include the Pfizer Medical Research Award and Best Abstract recognition at international conferences. A prolific author, he has published extensively in top-tier journals, advancing understanding and treatment of complex respiratory conditions. His dedication to medical excellence and patient care solidifies his standing as a global leader in respiratory medicine and allergy research.

Professional Profile

Scopus

Orcid

Google scholar

🌟  Prof. Dr. Yong Chul Lee Summary of Suitability for the Award

Dr. YongChul Lee, MD, PhD, is a highly accomplished and distinguished scholar in the field of respiratory medicine and allergy. His extensive academic background, professional achievements, and research contributions make him an exceptional candidate for the “Research for Best Researcher Award.”

Dr. Lee’s academic journey includes degrees from renowned institutions such as JEONBUK National University and a research fellowship at King’s College, University of London. His career spans over three decades, during which he has served as a professor, principal investigator, and director of several key research projects, including the Korea Healthcare Technology R&D Project and the Research Center for Severe Asthma. His commitment to advancing respiratory medicine is evident through his leadership roles, including serving as the President of The Korean Academy of Asthma, Allergy, and Clinical Immunology.

🎓  Education 

Dr. Lee embarked on his academic journey at JEONBUK National University Medical School, earning his BA in Medicine in 1985 and his MS in Internal Medicine in 1991. He completed his PhD in Pathology from Chonnam National University Medical School in 1993, demonstrating exceptional academic prowess. From 1996 to 1998, he served as a Research Fellow at King’s College, University of London, United Kingdom, where he honed his expertise in respiratory medicine. These experiences laid the foundation for his trailblazing research and clinical advancements in pulmonary diseases and allergy immunology. Dr. Lee’s commitment to continuous learning and innovation has driven his contributions to the medical field, making him a respected educator, mentor, and thought leader.

💼  Professional Experience

Dr. Lee’s illustrious career began as an instructor at JEONBUK National University Medical School in 1992. Rising through the ranks, he became Assistant Professor (1994), Associate Professor (1998), and Full Professor (2003). Since 2012, he has directed the Specialized Care Center for Respiratory and Allergic Diseases. He has also served as Chief of the Respiratory Medicine and Allergy Division at JEONBUK National University Hospital. In addition to his academic roles, Dr. Lee has been a principal investigator for numerous national and international projects, including the Korea Healthcare Technology R&D initiative and the National Research Laboratory for Airway Remodeling. His extensive leadership experience spans organizations like the Korean Academy of Asthma, Allergy, and Clinical Immunology, where he served as President. Through these roles, Dr. Lee has significantly influenced medical research, education, and policy.

🏅 Awards and Recognitions

Dr. Lee’s exceptional contributions have earned him numerous accolades. Notable honors include the Pfizer Medical Research Award (2009), Allergopharma Award (2004), and multiple Best Research Paper Awards from JEONBUK National University. He has also received prestigious citations from the Korean Ministry of Health and Welfare, including the Grand Prize for Health in 2008. In 2024, Dr. Lee was honored with the Best Abstract Award at the KATRD International Conference. His work has been consistently recognized for excellence, including Best Poster at the CHEST Challenge Championship and several Best Doctor awards in respiratory medicine. These distinctions reflect his dedication to advancing healthcare, education, and research in respiratory diseases and allergy immunology.

🌍 Research Skills On Medicine 

Dr. Lee is a pioneer in respiratory medicine and allergy research, with expertise in airway remodeling, severe asthma, and pulmonary immunology. His multidisciplinary approach integrates molecular biology, clinical trials, and innovative therapies. As a principal investigator, he has led groundbreaking studies on mitochondrial oxidative stress, endoplasmic reticulum stress, and respiratory drug development. Dr. Lee’s research employs advanced methodologies, including cohort studies and cryotherapy, addressing critical challenges in respiratory health. His collaborative work with international teams has yielded impactful findings, contributing to the development of targeted treatments for complex conditions. With an extensive publication record in high-impact journals, Dr. Lee is a thought leader in translating research into clinical practice.

📖 Publication Top Notes

Title: Impact of oxidative stress on lung diseases
    • Authors: HS Park, SR Kim, YC Lee
    • Citations: 395
    • Year: 2009
Title: Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model
    • Authors: KS Lee, HK Lee, JS Hayflick, YC Lee, KD Puri
    • Citations: 338
    • Year: 2006
Title: Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma
    • Authors: YG Kwak, CH Song, KY Ho, PH Hwang, JS Kim, KS Lee, YC Lee
    • Citations: 317
    • Year: 2003
Title: Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities
    • Authors: YM Kim, HO Pae, JE Park, YC Lee, JM Woo, NH Kim, YK Choi, BS Lee, et al.
    • Citations: 266
    • Year: 2011
Title: Inhibition of endoplasmic reticulum stress alleviates lipopolysaccharide-induced lung inflammation through modulation of NF-κB/HIF-1α signaling pathway
    • Authors: HJ Kim, JS Jeong, SR Kim, SY Park, HJ Chae, YC Lee
    • Citations: 212
    • Year: 2013
Title: NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation
    • Authors: SR Kim, DI Kim, SH Kim, H Lee, KS Lee, SH Cho, YC Lee
    • Citations: 211
    • Year: 2014
Title: Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma
    • Authors: YC Lee, YG Kwak, CH Song
    • Citations: 210
    • Year: 2002
Title: PPAR‐gamma modulates allergic inflammation through up‐regulation of PTEN
    • Authors: KS Lee, SJ Park, PH Hwang, HK Yi, CH Song, OH Chai, JS Kim, MK Lee, YC Lee
    • Citations: 182
    • Year: 2005
Title: Interleukin-17 regulation: an attractive therapeutic approach for asthma
    • Authors: SJ Park, YC Lee
    • Citations: 177
    • Year: 2010
Title: Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation
    • Authors: SR Kim, DI Kim, MR Kang, KS Lee, SY Park, JS Jeong, YC Lee
    • Citations: 155
    • Year: 2013